13.58
Avantor Inc stock is traded at $13.58, with a volume of 11.77M.
It is up +0.89% in the last 24 hours and up +7.01% over the past month.
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
See More
Previous Close:
$13.46
Open:
$13.46
24h Volume:
11.77M
Relative Volume:
1.00
Market Cap:
$9.33B
Revenue:
$6.82B
Net Income/Loss:
$309.60M
P/E Ratio:
30.18
EPS:
0.45
Net Cash Flow:
$747.20M
1W Performance:
+2.18%
1M Performance:
+7.01%
6M Performance:
-36.42%
1Y Performance:
-38.47%
Avantor Inc Stock (AVTR) Company Profile
Name
Avantor Inc
Sector
Industry
Phone
(610) 386-1700
Address
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
AVTR
Avantor Inc
|
13.58 | 9.33B | 6.82B | 309.60M | 747.20M | 0.45 |
![]()
ISRG
Intuitive Surgical Inc
|
521.63 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
170.90 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
87.57 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
257.91 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
221.02 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-29-25 | Downgrade | Goldman | Buy → Neutral |
Apr-28-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Apr-28-25 | Downgrade | Stifel | Buy → Hold |
Apr-28-25 | Downgrade | TD Cowen | Buy → Hold |
Jan-17-25 | Downgrade | UBS | Buy → Neutral |
Aug-28-24 | Initiated | Wells Fargo | Overweight |
Jul-10-24 | Downgrade | Citigroup | Buy → Neutral |
Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
Dec-11-23 | Upgrade | TD Cowen | Market Perform → Outperform |
Sep-28-23 | Initiated | Bernstein | Mkt Perform |
Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
Jul-31-23 | Downgrade | William Blair | Outperform → Mkt Perform |
Jun-21-23 | Initiated | RBC Capital Mkts | Outperform |
Dec-14-22 | Initiated | Deutsche Bank | Hold |
Oct-05-22 | Upgrade | Citigroup | Neutral → Buy |
Sep-14-22 | Downgrade | Cowen | Outperform → Market Perform |
Sep-09-22 | Downgrade | Cleveland Research | Buy → Neutral |
Aug-25-22 | Initiated | Credit Suisse | Neutral |
Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
Oct-15-21 | Resumed | Cowen | Outperform |
Aug-30-21 | Resumed | Raymond James | Outperform |
Aug-05-21 | Resumed | Credit Suisse | Outperform |
Aug-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
Jun-04-21 | Initiated | Goldman | Buy |
Apr-29-21 | Upgrade | Stifel | Hold → Buy |
Mar-03-21 | Initiated | Barclays | Overweight |
Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
Sep-14-20 | Initiated | Morgan Stanley | Overweight |
Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
Jan-08-20 | Initiated | Wells Fargo | Overweight |
Jan-07-20 | Initiated | Citigroup | Buy |
Nov-15-19 | Initiated | Stifel | Hold |
Aug-02-19 | Initiated | Cleveland Research | Neutral |
Jun-14-19 | Initiated | Janney | Buy |
Jun-12-19 | Initiated | Raymond James | Outperform |
Jun-11-19 | Initiated | Goldman | Buy |
Jun-11-19 | Initiated | Guggenheim | Buy |
Jun-11-19 | Initiated | JP Morgan | Overweight |
Jun-11-19 | Initiated | Jefferies | Buy |
Jun-11-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
Jun-11-19 | Initiated | Piper Jaffray | Neutral |
Jun-11-19 | Initiated | RBC Capital Mkts | Outperform |
Jun-11-19 | Initiated | Robert W. Baird | Outperform |
Jun-11-19 | Initiated | SunTrust | Buy |
Jun-11-19 | Initiated | UBS | Buy |
Jun-11-19 | Initiated | William Blair | Outperform |
View All
Avantor Inc Stock (AVTR) Latest News
Avantor Inc (AVTR) Shares Up 3.23% on Jun 4 - GuruFocus
KeyBanc maintains overweight rating on Avantor stock amid catalysts By Investing.com - Investing.com South Africa
PH Adjuster Memory Market Detailed in New Research Report | Avantor Inc., Thermo Fisher Scientific - openPR.com
KeyBanc maintains overweight rating on Avantor stock amid catalysts - Investing.com
RAYMOND JAMES REITERATES OUTPERFORM RATING FOR AVANTOR STOCK By Investing.com - Investing.com India
Policy Uncertainty Pulled Down Avantor (AVTR) - Insider Monkey
RAYMOND JAMES REITERATES OUTPERFORM RATING FOR AVANTOR STOCK - Investing.com
Long Term Trading Analysis for (AVTR) - news.stocktradersdaily.com
Avantor’s SWOT analysis: stock faces headwinds amid leadership change By Investing.com - Investing.com South Africa
Avantor's SWOT analysis: stock faces headwinds amid leadership change - Investing.com Australia
Avantor’s SWOT analysis: stock faces headwinds amid leadership change - Investing.com
Avantor Board Member Makes $253K Stock Purchase - Nasdaq
Avantor (AVTR) Faces Neutral Rating with Potential Downside | AV - GuruFocus
Avantor (AVTR) Faces Neutral Rating with Potential Downside | AVTR Stock News - GuruFocus
Avantor Inc (AVTR) Stock Price Down 4.16% on May 21 - GuruFocus
Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know - FinancialContent
(AVTR) Trading Advice - news.stocktradersdaily.com
Avantor CEO Michael Stubblefield to Speak at 2025 Bank of America Health Care Conference - MSN
Transcript : Avantor, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-20-2025 08 - marketscreener.com
Avantor at RBC Healthcare Conference: Navigating Market Challenges By Investing.com - Investing.com India
Avantor at RBC Healthcare Conference: Navigating Market Challenges - Investing.com
Avantor CEO Michael Stubblefield to Step Down, Search for Successor Underway - MSN
Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference - GuruFocus
Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference – Company Announcement - Financial Times
Is Avantor, Inc. (AVTR) The Most Undervalued Stock With Smart Money Ratings? - Insider Monkey
Avantor (AVTR) Sees Significant Stake Acquisition by UBS | AVTR Stock News - GuruFocus
Earnings Working Against Avantor, Inc.'s (NYSE:AVTR) Share Price - simplywall.st
Avantor at BofA Conference: Strategic Insights Amid CEO Transition By Investing.com - Investing.com Nigeria
Avantor at BofA Conference: Strategic Insights Amid CEO Transition - Investing.com
Transcript : Avantor, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 10 - marketscreener.com
Avantor adopts new executive severance policy By Investing.com - Investing.com South Africa
Avantor adopts new executive severance policy - Investing.com
Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know - Yahoo Finance
AVTR Q1 Earnings Call: CEO Transition and Margin Focus Amid Weak Market Conditions - Yahoo Finance
Q1 Earnings Highs And Lows: Avantor (NYSE:AVTR) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Biopreservation Industry Worth $7.1 billion by 2029, with a CAGR of 9.8% - The Globe and Mail
Viatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors - PR Newswire
Is Avantor, Inc. (AVTR) One of the Best Falling Stocks to Buy According to Analysts? - Insider Monkey
Avantor's (NYSE:AVTR) Profits Appear To Have Quality Issues - Yahoo Finance
Avantor® to Participate in Bank of America Securities 2025 Health Care Conference - BioSpace
Avantor® to Participate in Bank of America Securities 2025 Healt - GuruFocus
Exclusive: Avantor CEO Sets Stage for Strategic Updates at BofA Healthcare Conference - Stock Titan
Avantor in Radnor Is Losing Longtime CEO Michael Stubblefield - DELCO.Today
Avantor Inc Stock (AVTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Avantor Inc Stock (AVTR) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
SUMME GREGORY L | Director |
May 22 '25 |
Buy |
12.65 |
20,000 |
253,000 |
70,000 |
SUMME GREGORY L | Director |
May 07 '25 |
Buy |
12.00 |
25,000 |
300,000 |
50,000 |
Massaro Joseph R | Director |
Apr 29 '25 |
Buy |
12.30 |
8,100 |
99,630 |
35,038 |
SUMME GREGORY L | Director |
Apr 28 '25 |
Buy |
12.50 |
25,000 |
312,500 |
25,000 |
Kang Lan | Director |
Apr 28 '25 |
Buy |
12.57 |
5,000 |
62,850 |
35,215 |
Peacock Jonathan M | Director |
Apr 28 '25 |
Buy |
12.81 |
8,091 |
103,646 |
202,715 |
Bramwell James | EVP Sales, Customer Excellence |
Feb 26 '25 |
Sale |
17.53 |
3,758 |
65,878 |
87,379 |
Bramwell James | EVP Sales, Customer Excellence |
Feb 27 '25 |
Sale |
17.00 |
774 |
13,158 |
86,605 |
Eck Steven W | SVP & Chief Accounting Officer |
Feb 26 '25 |
Sale |
17.53 |
4,907 |
86,020 |
40,604 |
Eck Steven W | SVP & Chief Accounting Officer |
Feb 27 '25 |
Sale |
17.00 |
1,033 |
17,561 |
39,571 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):